Meningioma
| Meningioma | |
|---|---|
| Other names | Meningeal tumor |
| An MRI of the brain, demonstrating the appearance of a meningioma | |
| Specialty | Neurosurgery, Neuro-oncology |
| Symptoms | None, seizures, dementia, trouble talking, vision problems, one sided weakness |
| Usual onset | Adults |
| Types | WHO Grade 1, 2, or 3 |
| Risk factors | Ionizing radiation, family history |
| Diagnostic method | Medical imaging |
| Differential diagnosis | Haemangiopericytoma, lymphoma, schwannoma, solitary fibrous tumour, metastasis |
| Treatment | Observation, surgery, radiation therapy |
| Medication | Anticonvulsants, corticosteroids |
| Prognosis | 95% ten year survival with complete removal |
| Frequency | c. 1 per 1,000 (US) |
Meningioma, also known as meningeal tumor, is typically a slow-growing tumor that forms from the meninges, the membranous layers surrounding the brain and spinal cord. Symptoms depend on the location and occur as a result of the tumor pressing on nearby tissue. Many cases never produce symptoms. Occasionally seizures, dementia, trouble talking, vision problems, one sided weakness, or loss of bladder control may occur.
Risk factors include exposure to ionizing radiation such as during radiation therapy, a family history of the condition, and neurofibromatosis type 2. They appear to be able to form from a number of different types of cells including arachnoid cells. Diagnosis is typically by medical imaging.
If there are no symptoms, periodic observation may be all that is required. Most cases that result in symptoms can be cured by surgery. Following complete removal fewer than 20% recur. If surgery is not possible or all the tumor cannot be removed, radiosurgery may be helpful. Chemotherapy has not been found to be useful. A small percentage grow rapidly and are associated with worse outcomes.
About one per thousand people in the United States are currently affected. Onset is usually in adults. In this group they represent about 30% of brain tumors. Women are affected about twice as often as men. Meningiomas were reported as early as 1614 by Felix Plater.